Cargando…

Dopaminergic Modulation of Sensory Attenuation in Parkinson's Disease: Is There an Underlying Modulation of Beta Power?

Background and Aims: Pathological high amplitude of beta oscillations is thought as the underlying mechanism of motor symptoms in Parkinson's disease (PD), in particular with regard to bradykinesia. In addition, abnormality in a neurophysiological phenomenon labeled sensory attenuation has been...

Descripción completa

Detalles Bibliográficos
Autores principales:	Macerollo, Antonella, Limousin, Patricia, Korlipara, Prasad, Foltynie, Tom, Edwards, Mark J., Kilner, James
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6759719/ https://www.ncbi.nlm.nih.gov/pubmed/31620072 http://dx.doi.org/10.3389/fneur.2019.01001

Ejemplares similares

High‐frequency peripheral vibration decreases completion time on a number of motor tasks
por: Macerollo, Antonella, et al.
Publicado: (2018)

Sensory Attenuation Assessed by Sensory Evoked Potentials in Functional Movement Disorders
por: Macerollo, Antonella, et al.
Publicado: (2015)

Theory of mind deficits in Parkinson’s disease are not modulated by dopaminergic medication
por: Usnich, Tatiana, et al.
Publicado: (2023)

Bradykinesia Is Driven by Cumulative Beta Power During Continuous Movement and Alleviated by Gabaergic Modulation in Parkinson's Disease
por: Prokic, Emma J., et al.
Publicado: (2019)

Non-pharmacological Treatment Challenges in Early Parkinson's Disease for Axial and Cognitive Symptoms: A Mini Review
por: Sharpe, Gabriella, et al.
Publicado: (2020)

Opicapone Efficacy and Tolerability in Parkinson's Disease Patients Reporting Insufficient Benefit/Failure of Entacapone
por: Vokurka, Petr, et al.
Publicado: (2020)

Chronic Subthalamic Nucleus Stimulation in Parkinson's Disease: Optimal Frequency for Gait Depends on Stimulation Site and Axial Symptoms
por: Di Giulio, Irene, et al.
Publicado: (2019)

Deep brain stimulation modulates synchrony within spatially and spectrally distinct resting state networks in Parkinson’s disease
por: Oswal, Ashwini, et al.
Publicado: (2016)

Dopaminergic Modulation of Prospective Memory in Parkinson’s Disease
por: Costa, Alberto, et al.
Publicado: (2008)

Structural connectivity and brain network analyses in Parkinson's disease: A cross-sectional and longitudinal study
por: Bergamino, Maurizio, et al.
Publicado: (2023)

Standardised Neuropsychological Assessment for the Selection of Patients Undergoing DBS for Parkinson's Disease
por: Foley, Jennifer A., et al.
Publicado: (2018)

Subthalamic Nucleus Deep Brain Stimulation in Parkinson’s Disease: The Effect of Varying Stimulation Parameters
por: Dayal, Viswas, et al.
Publicado: (2017)

In vivo Illustration of Altered Dopaminergic and GABAergic Systems in Early Parkinson's Disease
por: Takashima, Hirotsugu, et al.
Publicado: (2022)

Motivational modulation of bradykinesia in Parkinson’s disease off and on dopaminergic medication
por: Kojovic, Maja, et al.
Publicado: (2014)

Dopaminergic modulation of emotional conflict in Parkinson's disease
por: Fleury, Vanessa, et al.
Publicado: (2014)

Dopaminergic modulation of the praxis network in Parkinson's disease
por: Matt, Eva, et al.
Publicado: (2019)

Long-term success of low-frequency subthalamic nucleus stimulation for Parkinson’s disease depends on tremor severity and symptom duration
por: Vijiaratnam, Nirosen, et al.
Publicado: (2021)

Amplitude and frequency modulation of subthalamic beta oscillations jointly encode the dopaminergic state in Parkinson’s disease
por: Averna, Alberto, et al.
Publicado: (2022)

How Does Deep Brain Stimulation Change the Course of Parkinson's Disease?
por: Mahlknecht, Philipp, et al.
Publicado: (2022)

The Role of D(2)-like Dopaminergic Receptor in Dopamine-mediated Modulation of Th17-cells in Multiple Sclerosis
por: Melnikov, Mikhail, et al.
Publicado: (2022)

Association Between Dopaminergic Medications and the Evolution of REM Sleep Behavior Disorder in Parkinson's Disease
por: Cao, Ruihua, et al.
Publicado: (2022)

The effects of deep brain stimulation of the pedunculopontine nucleus on cognition in Parkinson's disease and Progressive Supranuclear Palsy()
por: Leimbach, Friederike, et al.
Publicado: (2019)

Implications of dopaminergic medication withdrawal in Parkinson’s disease
por: Koschel, J., et al.
Publicado: (2021)

Dopaminergic modulation of motor network dynamics in Parkinson’s disease
por: Michely, Jochen, et al.
Publicado: (2015)

Memory deficits in Parkinson’s disease are associated with reduced beta power modulation
por: MacDonald, Hayley J, et al.
Publicado: (2019)

Abnormal beta power is a hallmark of explicit movement control in functional movement disorders
por: Teodoro, Tiago, et al.
Publicado: (2018)

Dopaminergic Treatment Effects on Dysarthric Speech: Acoustic Analysis in a Cohort of Patients With Advanced Parkinson's Disease
por: Cavallieri, Francesco, et al.
Publicado: (2021)

Sensory feedback in Parkinson's disease patients with “on”-predominant freezing of gait
por: Espay, Alberto J., et al.
Publicado: (2013)

Subthalamic nucleus beta and gamma activity is modulated depending on the level of imagined grip force
por: Fischer, Petra, et al.
Publicado: (2017)

Dopaminergic Modulation of Medial Prefrontal Cortex Deactivation in Parkinson Depression
por: Andersen, Anders H., et al.
Publicado: (2015)

Dopaminergic Modulation of Biological Motion Perception in patients with Parkinson’s disease
por: Liu, Tingting, et al.
Publicado: (2017)

Alternating Modulation of Subthalamic Nucleus Beta Oscillations during Stepping
por: Fischer, Petra, et al.
Publicado: (2018)

Opioidergic Modulation of Striatal Circuits, Implications in Parkinson's Disease and Levodopa Induced Dyskinesia
por: Sgroi, Stefania, et al.
Publicado: (2018)

Characterization of bladder sensory neurons in the context of myelination, receptors for pain modulators, and acute responses to bladder inflammation
por: Forrest, Shelley L., et al.
Publicado: (2013)

Identification of nonlinear features in cortical and subcortical signals of Parkinson's Disease patients via a novel efficient measure
por: Özkurt, Tolga Esat, et al.
Publicado: (2020)

Deep Brain Stimulation Does Not Modulate Auditory-Motor Integration of Speech in Parkinson's Disease
por: Bahners, Bahne H., et al.
Publicado: (2020)

Beta Amyloid Deposition Is Not Associated With Cognitive Impairment in Parkinson's Disease
por: Melzer, Tracy R., et al.
Publicado: (2019)

The Discriminative Power of Different Olfactory Domains in Parkinson's Disease
por: Zhao, Yuwen, et al.
Publicado: (2020)

Dopaminergic Neurotransmission in Patients With Parkinson's Disease and Impulse Control Disorders: A Systematic Review and Meta-Analysis of PET and SPECT Studies
por: Martini, Alice, et al.
Publicado: (2018)

Do Naturally Occurring Antioxidants Protect Against Neurodegeneration of the Dopaminergic System? A Systematic Revision in Animal Models of Parkinson's Disease
por: Costas, Carmen, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_65l4jcqi3pger5o2gi4bn4ut51